pharmaphorum

MARCH 25, 2022

In their meta-analysis of published studies, the authors found universal deficiencies and concluded that there’s no convincing evidence that app-based interventions deliver meaningful outcomes. I reviewed all 14 meta-analyses included in the study and found the analysis to be accurate, but incomplete. Consistent Standards Matter.

113

113

pharmaphorum

APRIL 30, 2021

Turning words into actions with patient engagement. Boehringer Ingelheim’s Carinne Brouillon tells us how the company co-created its recent Global Patient Partnership Summit with patients. “A Experts from ICON give us their views on the past, present and future of NICE’s standing on the world stage.

Communication 98

Communication Pharmaceutical Companies Pharmaceutical Companies Vaccines 98

ALiEM - Pharm Pearls

DECEMBER 22, 2023

The patient reported a history of falls resulting in shoulder, rib, and left hip fractures in the past. The patient stated that upon getting out of bed, she took 4-5 steps, lost her balance, and fell backward onto the bedroom floor. In a 7-year retrospective analysis at a regional trauma center, 57.4%

158

158

pharmaphorum

DECEMBER 7, 2022

The HTA body, the CT ( Commission de la Transparence – Transparency Commission), is charged with providing guidance to inform pricing negotiations in two main forms: a comparative clinical benefit rating, the ASMR ( Amélioration du Service Médical Rendu ), and a target patient population. Relationship between ATC and eligible patient number.

Drug Pricing 104

Drug Pricing Drug Development 104

Pharmacy Joe

MAY 5, 2024

In this episode, I’ll discuss the problem with hypo-osmolar solutions in neurological patients. Episode 919: The problem with hypo-osmolar solutions in neurological patients Subscribe on iTunes , Android , or Stitcher The administration of hypo-osmolar IV solutions causes an increase in water into the brain.

Hospitals 52

Hospitals Inpatient 52

ALiEM - Pharm Pearls

MARCH 22, 2024

H) Case Question: What are some possible causes of this patient's right-sided internuclear ophthalmoplegia? Usually, MS is seen in younger patients where both eyes are affected whereas strokes occur more often in older patients and only one eye is affected. View other cases from this Clinical Image Series on ALiEM.

166

166

pharmaphorum

OCTOBER 26, 2020

A new analysis looks at these barriers and asks how they could be overcome. In addition to representing more efficient and cost-effective options in healthcare coverage, these measures offer the prospect of positive health outcomes and quality of life for patients. Understanding payer views of preventive care.

Vaccines 128

Vaccines 128

ALiEM - Pharm Pearls

SEPTEMBER 25, 2023

Management of bilateral phlegmasia cerulea dolens in a patient with subacute splenic laceration. A comparative analysis of the efficacy and safety of therapeutic interventions in phlegmasia cerulea dolens. View other cases from this Clinical Image Series on ALiEM. References Bazan HA, Reiner E, Sumpio B. Ann Vasc Dis.

Medical Schools 150

Medical Schools Diabetes 150

pharmaphorum

FEBRUARY 11, 2022

Rare diseases are challenging to identify, and the relatively small number of patients suffering from these diseases are dispersed across the globe. However, for patients with rare diseases, information can be pivotal yet unattainable. For us, it’s operating at the intersection between data and software.

104

104

Pharmacy Joe

FEBRUARY 25, 2024

Members of my Hospital Pharmacy Academy have access to practical training on the treatment of anaphylaxis from a pharmacist’s point of view. This is in addition to hundreds of other resources to help in your practice. To get immediate access, go to pharmacyjoe.com/academy.

Hospitals 75

Hospitals Inpatient 75

pharmaphorum

OCTOBER 28, 2021

As the world is slowly, gradually, hopefully emerges from the shadow of COVID-19 there’s a unique opportunity to re-discover what matters most to patients. Time for a new model in patient access. We now have a unique opportunity to re-discover what matters most to patients, says Alnylam’s Kasha Witkos.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Pharmacy Joe

AUGUST 20, 2023

In this episode, I’ll discuss how aggressively extremely high blood pressure should be managed in patients with ICH. Episode 845: How aggressively should extremely high blood pressure be managed in patients with ICH? Patients with intracerebral hemorrhage and initial systolic blood pressure of 180 mm Hg or more, randomized within 4.5

Hospitals 52

Hospitals Inpatient 52

Pharmacy Joe

AUGUST 20, 2023

In this episode, I’ll discuss how aggressively extremely high blood pressure should be managed in patients with ICH. Episode 845: How aggressively should extremely high blood pressure be managed in patients with ICH? Patients with intracerebral hemorrhage and initial systolic blood pressure of 180 mm Hg or more, randomized within 4.5

Hospitals 52

Hospitals Inpatient 52

pharmaphorum

JANUARY 22, 2021

Many physicians are also now reporting affordability issues among their patients. The survey focused on oncologists and neurologists, two specialties that regularly see immunocompromised patients receiving long-term treatment, and also surveyed pulmonologists and urologists to gauge the wider impact on prescribing habits.

Specialty Pharmacies 103

Specialty Pharmacies Pharmaceutical Companies Pharmaceutical Companies Vaccines 103

Safe Biologics

JANUARY 12, 2024

The episode features three former government officials who worked on the development and implementation of Medicare Part D as well as two leading patient advocates. View video of the podcast here. The episode was released December 27th. Read ASBM’s full comments to the Oregon PDAB here.

Biosimilars 130

Biosimilars Drug Pricing 130

pharmaphorum

AUGUST 24, 2020

Could collecting, understanding, and disseminating patient-reported outcomes during trials be the key to advancing oncology treatments and improving cancer outcomes? . Project Patient Voice . Overall, it aims to advance the development and regulation of oncology drugs, and make patient experience “more visible”. .

Labelling 127

Labelling Communication Drug Development 127

Express Pharma

APRIL 2, 2024

An analysis by McKinsey has projected that on account of broader adoption of these technologies, the EBIDTA earnings of the Indian pharma industry will go up by 45-75 per cent in the next 10 years. A leading multinational is aptly using AI systems to build clinical decision-making tools to develop personalised medicine for cancer patients.

Drug Development 59

Drug Development Clinic Management Communication 59

pharmaphorum

OCTOBER 27, 2020

Collecting and analysing anonymised patient data has the potential to generate valuable insights that can catalyse research, lead to improved patient care, and power the development of new treatments. This is because typically, ‘real-world’ medical data is collected from patients who are ill.

Diabetes 113

Diabetes Medical Records Hospitals 113

pharmaphorum

OCTOBER 20, 2022

Together, these groups compile vast amounts of data, including rich information on patient populations, target customers, and the competitive landscape. Historically, competitive and market analysis data has been stored in spreadsheets. Historically, competitive and market analysis data has been stored in spreadsheets.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies Data Entry Documentation 98

pharmaphorum

DECEMBER 17, 2021

Read on for a look at some of the biggest stories from Frontiers Health, how digital is making healthcare more patient-friendly and key ways to optimise decentralised clinical trials. A multi-platform approach: the future of patient services. Accelerating patient engagement in the digital health era.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

AUGUST 4, 2020

Several factors make it difficult for HTA bodies often to assess orphan drugs, including a lack of robust trial data due to difficulties in finding patients, the absence of randomised controlled trials, the use of surrogate endpoints, and the lack of active drug comparators. Source: CRA Analysis. Source: CRA Analysis.

Labelling 120

Labelling 120

pharmaphorum

DECEMBER 14, 2020

As this issue’s title suggests, patient centricity is about more than just talking points and marketing strategies – it requires companies to truly listen to, engage with and partner with the patients they serve, and in putting this month’s Deep Dive together it’s been great to see that so many pharma firms are now taking this to heart.

Pharmaceutical Companies 72

Pharmaceutical Companies Pharmaceutical Companies 72

Pharmacy Joe

OCTOBER 23, 2022

Subscribe on iTunes , Android , or Stitcher Some clinicians prefer phenobarbital over benzodiazepines for alcohol withdrawal patients presenting to the emergency department. Just over 1500 patients were represented in the studies. Like benzos, phenobarbital targets gamma-aminobutyric acid (GABA) receptors in the central nervous system.

Hospitals 52

Hospitals Inpatient 52

pharmaphorum

OCTOBER 1, 2021

This issue assesses European pharma’s approach to strategic communications, the future of pharma commercialisation, communications gaps with patients and, with the pandemic continuing to cast a long shadow over healthcare, how to maximise the effectiveness of HCP engagement. Closing pharma’s communication gap with patients.

Communication 52

Communication Pharmaceutical Companies Pharmaceutical Companies Drug Development 52

Express Pharma

JUNE 5, 2023

GlobalData’s latest report, ‘Myelofibrosis: Eight-Market Drug Forecast and Market Analysis,’ reveals that the MF market will grow from $2.39 As the anaemia worsens over time, the patients are required to stop taking Jakafi and have few treatment options left. billion in 2021 to $2.89

Drug Development 88

Drug Development Biosimilars Compounding 88

Big Molecule Watch

JANUARY 26, 2024

The USPTO requested the remand so that the USPTO’s Appeals Review Panel can “clarify the USPTO’s position on the proper analysis of Jepson-format and means-plus function claims in the field of biotechnology, and particularly in the antibody art,” and issue “a revised decision.” No 16/803,690 (“’690 patent application”) back to the USPTO.

62

62

pharmaphorum

OCTOBER 8, 2021

The idea is that analysis of the digital twin allows the health of the user can be continuously monitored, and advice delivered to the user on nutrition, sleep, activity and breathing via an app. After four months of using the digital twin platform, patients had an average HbA1c reduction – a measure of blood glucose control – of 3.1

Diabetes 143

Diabetes 143

Pharmacy Joe

FEBRUARY 25, 2024

Members of my Hospital Pharmacy Academy have access to practical training on the treatment of anaphylaxis from a pharmacist’s point of view. This is in addition to hundreds of other resources to help in your practice. To get immediate access, go to pharmacyjoe.com/academy.

Hospitals 40

Hospitals Inpatient 40

ALiEM - Pharm Pearls

MARCH 7, 2024

Examine the patient in a position that maximizes comfort and minimizes anxiety. Lay the patient supine when possible. This is also an optimal position in which the parent can hold a tablet or smart device above the patient’s face as a distractor. In this position, the parent can hug and hold the patient if needed.

Labelling 174

Labelling Communication 174

Pharmaceutical Technology

APRIL 13, 2023

Following the increased use of telemedicine during the Covid-19 pandemic, the potential of digital technologies in communication, data collection, and analysis has become increasingly realised by patients, healthcare systems, and clinical trial sponsors. However, there is still some use of remote patient monitoring technologies.

Documentation 52

Documentation Communication 52

ID Stewardship

NOVEMBER 26, 2023

Beta-lactams such as piperacillin-tazobactam, cefepime, and meropenem form the backbone of antibiotic regimens in the sickest, most vulnerable hospitalized patients. Question 2: Which patients should have beta-lactam TDM performed? We will use a case to emphasize some points. Let us begin!

Nursing Homes 94

Nursing Homes Hospitals Dosage 94

European Pharmaceutical Review

MARCH 12, 2024

The function of the coating ranges from purely cosmetic improvements (brand recognition, better patient acceptance using API taste masking) to alterations of tablet release characteristics (control of the release profile and bioavailability of the API). Coating is the oldest and last key unit operation in many tablet production processes.

Dosage 84

Dosage 84

pharmaphorum

NOVEMBER 11, 2020

Abid Rahman from Intouch Group tells pharmaphorum how AI-based technology is solving challenges across healthcare systems, pharmaceutical companies, and patient treatment. We can put AI use cases in three buckets – healthcare and hospital systems, pharmaceutical companies and patient and caregivers.”. Key challenges.

Pharmaceutical Companies 139

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 139

pharmaphorum

MAY 6, 2022

Read on to find out how diverse viewpoints are reshaping value, the importance of making patient centricity a reality, and much more. How do we make patient centricity a reality? Giving patients a seat at the table is essential as real-time patient data gains prominence. Closing the digital expectation gap in pharma.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JULY 13, 2021

As part of that work, NICE is engaging widely with stakeholders, including patient organisations. Leela Barham provides an independent view of patient organisations responses to a NICE online survey and highlights the opportunity for other stakeholders to share their views on NICE through an online survey open until 16 July 2021.

Communication 57

Communication 57

pharmacy mentor

MARCH 12, 2023

In this article, we’ll explore the pharmacy industry landscape before and after the pharmacy digital revolution, with a focus on the impact of digital marketing on patient behaviour and experience. 34.7million views of our Google Adverts for pharmacies since 2021. 34.7million views of our Google Adverts for pharmacies since 2021.

Community Pharmacies 97

Community Pharmacies Online Pharmacies Prescription Filling Packaging 97

pharmaphorum

JULY 8, 2022

Preliminary research suggests that hybrid DCTs can reduce trial timing and resources , improve patient-centricity and patient engagement , and expand access and recruitment and increase diversity , mitigate bias, and reinforce inclusion in clinical trials.

Drug Development 98

Drug Development Diabetes 98